Adell Harriman & Carpenter’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-480	Closed	-$252K	–	179
2025 Q2	$252K	Buy	480 +4	+0.8%	+$2.23K	0.02%	157
2025 Q1	$302K	Sell	476 -27	-5%	-$18.6K	0.02%	150
2024 Q4	$358K	Hold	503	–	–	0.02%	138
2024 Q3	$529K	Hold	503	–	–	0.04%	121
2024 Q2	$529K	Sell	503 -4	-0.8%	-$3.88K	0.04%	117
2024 Q1	$488K	Hold	507	–	–	0.04%	128
2023 Q4	$445K	Buy	507 +126	+33%	+$104K	0.04%	123
2023 Q3	$314K	Hold	381	–	–	0.03%	141
2023 Q2	$274K	Sell	381 -8	-2%	-$6.17K	0.03%	150
2023 Q1	$320K	Buy	389 +32	+9%	+$24.1K	0.03%	145
2022 Q4	$258K	Hold	357	–	–	0.03%	156
2022 Q3	$246K	Buy	+357	New	+$225K	0.03%	157
2022 Q2	–	Sell	-360	Closed	-$251K	–	166
2022 Q1	$251K	Sell	360 -1	-0.3%	-$633	0.02%	160
2021 Q4	$228K	Buy	+361	New	+$222K	0.02%	170